BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 31238829)

  • 1. Identification and Validation of Hematoma Volume Cutoffs in Spontaneous, Supratentorial Deep Intracerebral Hemorrhage.
    Leasure AC; Sheth KN; Comeau M; Aldridge C; Worrall BB; Vashkevich A; Rosand J; Langefeld C; Moomaw CJ; Woo D; Falcone GJ
    Stroke; 2019 Aug; 50(8):2044-2049. PubMed ID: 31238829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different Effects of Hematoma Expansion on Short-Term Functional Outcome in Basal Ganglia and Thalamic Hemorrhages.
    Deng L; Chen K; Yang L; Deng Z; Zheng H
    Biomed Res Int; 2021; 2021():9233559. PubMed ID: 34734087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive Blood Pressure Reduction and Perihematomal Edema Expansion in Deep Intracerebral Hemorrhage.
    Leasure AC; Qureshi AI; Murthy SB; Kamel H; Goldstein JN; Walsh KB; Woo D; Shi FD; Huttner HB; Ziai WC; Hanley DF; Matouk CC; Sansing LH; Falcone GJ; Sheth KN
    Stroke; 2019 Aug; 50(8):2016-2022. PubMed ID: 31272326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Location-specific differences in hematoma volume predict outcomes in patients with spontaneous intracerebral hemorrhage.
    Ironside N; Chen CJ; Dreyer V; Christophe B; Buell TJ; Connolly ES
    Int J Stroke; 2020 Jan; 15(1):90-102. PubMed ID: 30747614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal Hematoma Volume Cut Points to Predict Functional Outcome After Basal Ganglia and Thalamic Hemorrhages.
    Nakagawa K; King SL; Seto TB
    Front Neurol; 2018; 9():291. PubMed ID: 29765352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal intraventricular hemorrhage volume cutoff for predicting poor outcome in patients with intracerebral hemorrhage.
    Deng L; Zhang JT; Lv XN; Li ZQ; Chen C; Hu X; Yin H; Yang TN; Zhang ZH; Li Q
    J Stroke Cerebrovasc Dis; 2024 Jun; 33(6):107683. PubMed ID: 38513767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Location-Specific Hematoma Volume Cutoff and Clinical Outcomes in Intracerebral Hemorrhage.
    Teo KC; Fong SM; Leung WCY; Leung IYH; Wong YK; Choi OMY; Yam KK; Lo RCN; Cheung RTF; Ho SL; Tsang ACO; Leung GKK; Chan KH; Lau KK
    Stroke; 2023 Jun; 54(6):1548-1557. PubMed ID: 37216445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of hematoma volume in deep and lobar supratentorial intracerebral hemorrhage.
    Falcone GJ; Biffi A; Brouwers HB; Anderson CD; Battey TW; Ayres AM; Vashkevich A; Schwab K; Rost NS; Goldstein JN; Viswanathan A; Greenberg SM; Rosand J
    JAMA Neurol; 2013 Aug; 70(8):988-94. PubMed ID: 23733000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Intensive Blood Pressure Reduction With Risk of Hematoma Expansion in Patients With Deep Intracerebral Hemorrhage.
    Leasure AC; Qureshi AI; Murthy SB; Kamel H; Goldstein JN; Woo D; Ziai WC; Hanley DF; Al-Shahi Salman R; Matouk CC; Sansing LH; Sheth KN; Falcone GJ
    JAMA Neurol; 2019 Aug; 76(8):949-955. PubMed ID: 31081862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Deterioration, Hematoma Expansion, and Outcomes in Deep Versus Lobar Intracerebral Hemorrhage: The FAST Trial.
    Kuohn LR; Witsch J; Steiner T; Sheth KN; Kamel H; Navi BB; Merkler AE; Murthy SB; Mayer SA
    Stroke; 2022 Aug; 53(8):2441-2448. PubMed ID: 35360929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematoma expansion is more frequent in deep than lobar intracerebral hemorrhage.
    Roh D; Boehme A; Young C; Roth W; Gutierrez J; Flaherty M; Rosand J; Testai F; Woo D; Elkind MSV
    Neurology; 2020 Dec; 95(24):e3386-e3393. PubMed ID: 33219144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the association between location and patient prognosis in spontaneous intracerebral hemorrhage in the basal ganglia and thalamus: A retrospective single-center study.
    Park JS; Jang HG
    Medicine (Baltimore); 2022 Dec; 101(48):e32000. PubMed ID: 36482580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining Investigation of Imaging Markers (Island Sign and Blend Sign) and Clinical Factors in Predicting Hematoma Expansion of Intracerebral Hemorrhage in the Basal Ganglia.
    Huang YW; Yang MF
    World Neurosurg; 2018 Dec; 120():e1000-e1010. PubMed ID: 30201578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimum Baseline Clinical Severity Scale Cut Points for Prognosticating Intracerebral Hemorrhage: INTERACT Studies.
    You S; Zheng D; Yoshimura S; Ouyang M; Han Q; Wang X; Cao Y; Delcourt C; Song L; Arima H; Chen X; Liu CF; Lindley RI; Robinson T; Anderson CS; Chalmers J;
    Stroke; 2024 Jan; 55(1):139-145. PubMed ID: 38018833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel risk score to predict 1-year functional outcome after intracerebral hemorrhage and comparison with existing scores.
    Ji R; Shen H; Pan Y; Wang P; Liu G; Wang Y; Li H; Zhao X; Wang Y;
    Crit Care; 2013 Nov; 17(6):R275. PubMed ID: 24289116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A reliable grading system for prediction of hematoma expansion in intracerebral hemorrhage in the basal ganglia.
    Huang Y; Zhang Q; Yang M
    Biosci Trends; 2018; 12(2):193-200. PubMed ID: 29760358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear factor-κB activation in perihematomal brain tissue correlates with outcome in patients with intracerebral hemorrhage.
    Zhang ZL; Liu YG; Huang QB; Wang HW; Song Y; Xu ZK; Li F
    J Neuroinflammation; 2015 Mar; 12():53. PubMed ID: 25889503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A practical prediction model for early hematoma expansion in spontaneous deep ganglionic intracerebral hemorrhage.
    Takeda R; Ogura T; Ooigawa H; Fushihara G; Yoshikawa S; Okada D; Araki R; Kurita H
    Clin Neurol Neurosurg; 2013 Jul; 115(7):1028-31. PubMed ID: 23245855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using 30-day modified rankin scale score to predict 90-day score in patients with intracranial hemorrhage: Derivation and validation of prediction model.
    Baker WL; Sharma M; Cohen A; Ouwens M; Christoph MJ; Koch B; Moore TE; Frady G; Coleman CI
    PLoS One; 2024; 19(5):e0303757. PubMed ID: 38771834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral Microbleeds and the Effect of Intensive Blood Pressure Reduction on Hematoma Expansion and Functional Outcomes: A Secondary Analysis of the ATACH-2 Randomized Clinical Trial.
    Shoamanesh A; Morotti A; Romero JM; Oliveira-Filho J; Schlunk F; Jessel MJ; Ayres AM; Vashkevich A; Schwab K; Afzal MR; Cassarly C; Martin RH; Qureshi AI; Greenberg SM; Rosand J; Goldstein JN;
    JAMA Neurol; 2018 Jul; 75(7):850-859. PubMed ID: 29710119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.